Drugs / Galmydar
Galmydar
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05280782 | Jan → May 2022 | coronary artery disorder | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Galmydar | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05280782 ↗ |
| Known as | 68Ga-Galmydar | “Single intravenous injection of the PET radiotracer 68Ga-Galmydar.” NCT05280782 ↗ |
| Known as | Ga-68 Galmydar | “Drug: Ga-68 Galmydar” NCT05280782 ↗ |
| Modality | Diagnostic / imaging agent | “PET radiotracer” NCT05280782 ↗ |
| Route | Intravenous | “Single intravenous injection” NCT05280782 ↗ |